BackImpel Pharmaceuticals Overview

Impel Pharmaceuticals Operating Income

Operating Income for IMPL.

Quarterly Operating Income

$-12811000.00
↓ 39.68% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$-70109000.00
↓ 21.4% YoY

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin